| [1] |
Cordell CB, Borson S, Boustani M, et al. Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting[J].Alzheimers Dement, 2013, 9(2): 141-150.
|
| [2] |
Sabbagh MN. Drug development for Alzheimer's disease: where are we now and where are we headed[J]? Am J Geriatr Pharmacother, 2009, 7(3): 167-185.
|
| [3] |
Dickson JR, Kruse C, Montagna DR, et al. Alternative polyadenylation and miR-34 family members regulate tau expression[J]. J Neurochem, 2013, 127(6): 739-749.
|
| [4] |
Dong H, Li J, Huang L, et al. Serum microRNA profiles serve as novel biomarkers for the diagnosis of Alzheimer's disease[J]. Dis Markers, 2015, 2015: 625659.
|
| [5] |
Esquela-Kerscher A, Slack FJ, Oncomirs-microRNAs with a role in cancer[J]. Nat Rev Cancer, 2006, 6(4): 259-269.
|
| [6] |
Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease[J]? Circ Res, 2012, 110(3): 483-495.
|
| [7] |
Jung HJ, Suh Y. Circulating miRNAs in ageing and ageing-related diseases[J]. J Genet Genomics, 2014, 41(9): 465-472.
|
| [8] |
Noren Hooten N, Fitzpatrick M, Wood WH, et al. Age-related changes in microRNA levels in serum[J]. Aging (Albany NY), 2013, 5(10): 725-740.
|
| [9] |
Turchinovich A, Samatov TR, Tonevitsky AG, et al. Circulating miRNAs: cell-cell communication function[J]? Front Genet, 2013, 4:119.
|
| [10] |
Grasso M, Piscopo P, Confaloni A, et al. Circulating miRNAs as biomarkers for neurodegenerative disorders[J]. Molecules, 2014, 19(5): 6891-6910.
|
| [11] |
He Y, Lin J, Kong D, et al. Current state of circulating microRNAs as cancer biomarkers[J]. Clin Chem, 2015, 61(9): 1138-1155.
|
| [12] |
Ma R, Jiang T, Kang X. Circulating microRNAs in cancer: origin, function and application[J]. J Exp Clin Cancer Res, 2012, 31: 38.
|
| [13] |
Schwarzenbach H, Nishida N, Calin GA, et al. Clinical relevance of circulating cell-free microRNAs in cancer[J]. Nat Rev Clin Oncol, 2014, 11(3): 145-156.
|
| [14] |
Geekiyanage H, Chan C. MicroRNA-137/181c regulates serine palmitoyltransferase and in turn amyloidβ, novel targets in sporadic Alzheimer's disease[J]. J Neurosci, 2011, 31(41): 14820-14830.
|
| [15] |
Geekiyanage H, Jicha GA, Nelson PT, et al. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease[J]. Exp Neurol, 2012, 235(2): 491-496.
|
| [16] |
Wu Y, Xu J, Xu J, et al. Lower Serum Levels of miR-29c-3p and miR-19b-3p as biomarkers for Alzheimer's disease[J]. Tohoku J Exp Med, 2017, 242(2): 129-136.
|
| [17] |
Galimberti D, Villa C, Fenoglio C, et al. Circulating miRNAs as potential biomarkers in Alzheimer's disease[J]. J Alzheimers Dis, 2014, 42(4): 1261-1267.
|
| [18] |
Sheinerman KS, Umansky SR. Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies[J]. Front Cell Neurosci, 2013, 7: 150.
|
| [19] |
Tan L, Yu JT, Liu QY, et al. Circulating miR-125b as a biomarker of Alzheimer's disease[J]. J Neurol Sci, 2014, 336(1-2):52-56.
|
| [20] |
Tan L, Yu JT, Tan MS, et al. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease[J]. J Alzheimers Dis, 2014, 40(4): 1017-1027.
|
| [21] |
Schipper HM, Maes OC, Chertkow HM, et al. MicroRNA expression in Alzheimer blood mononuclear cells[J]. Gene Regul Syst Bio, 2007, 1: 263-274.
|
| [22] |
Bhatnagar S, Chertkow H, Schipper HM, et al. Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma[J]. Front Mol Neurosci, 2014, 7: 2.
|
| [23] |
La Fauci G, Lahiri DK, Salton SR, et al. Characterization of the 5'-end region and the first two exons of the beta-protein precursor gene[J]. Biochem Biophys Res Commun, 1989, 159(1):297-304.
|
| [24] |
Heicklen-Klein A, Ginzburg I. Tau promoter confers neuronal specificity and binds Sp1 and AP-2[J]. J Neurochem, 2000, 75(4): 1408-1418.
|
| [25] |
Villa C, Ridolfi E, Fenoglio C, et al. Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease[J].J Alzheimers Dis, 2013, 35(3): 487-494.
|
| [26] |
Satoh J, Kino Y, Niida S. MicroRNA-seq data analysis pipeline to identify blood biomarkers for Alzheimer's disease from public data[J]. Biomark Insights, 2015, 10: 21-31.
|
| [27] |
Kumar P, Dezso Z, MacKenzie C, et al. Circulating miRNA biomarkers for Alzheimer's disease[J]. PLoS One, 2013, 8(7): e69807.
|
| [28] |
Bekris LM, Lutz F, Montine TJ, et al. MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma[J]. Biomarkers, 2013, 18(5): 455-466.
|
| [29] |
刘辰庚，王金玲，李蕾，等.阿尔茨海默病患者血液标本外吐小体中miRNA-135a的检测[J].现代生物医学进展, 2013, 13(22): 4361-4363.
|
| [30] |
Lugli G, Cohen AM, Bennett DA, et al. Plasma exosomal miRNAs in persons with and without Alzheimer's disease: altered expression and prospects for biomarkers[J]. PLoS One, 2015, 10(10): e0139233.
|
| [31] |
Cheng L, Doecke JD, Sharples RA, et al. Prognostic serum miRNA biomarkers associated with Alzheimer's disease shows concordance with neuropsychological and neuroimaging assessment[J].Mol Psychiatry, 2015, 20(10): 1188-1196.
|